BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30760892)

  • 1. Phenotype of CM-AVM2 caused by variants in EPHB4: how much overlap with hereditary hemorrhagic telangiectasia (HHT)?
    Wooderchak-Donahue WL; Akay G; Whitehead K; Briggs E; Stevenson DA; O'Fallon B; Velinder M; Farrell A; Shen W; Bedoukian E; Skrabann CM; Antaya RJ; Henderson K; Pollak J; Treat J; Day R; Jacher JE; Hannibal M; Bontempo K; Marth G; Bayrak-Toydemir P; McDonald J
    Genet Med; 2019 Sep; 21(9):2007-2014. PubMed ID: 30760892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling.
    Amyere M; Revencu N; Helaers R; Pairet E; Baselga E; Cordisco M; Chung W; Dubois J; Lacour JP; Martorell L; Mazereeuw-Hautier J; Pyeritz RE; Amor DJ; Bisdorff A; Blei F; Bombei H; Dompmartin A; Brooks D; Dupont J; González-Enseñat MA; Frieden I; Gérard M; Kvarnung M; Hanson-Kahn AK; Hudgins L; Léauté-Labrèze C; McCuaig C; Metry D; Parent P; Paul C; Petit F; Phan A; Quere I; Salhi A; Turner A; Vabres P; Vicente A; Wargon O; Watanabe S; Weibel L; Wilson A; Willing M; Mulliken JB; Boon LM; Vikkula M
    Circulation; 2017 Sep; 136(11):1037-1048. PubMed ID: 28687708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and molecular characterization of patients with hereditary hemorrhagic telangiectasia: Experience from an HHT Center of Excellence.
    Latif MA; Sobreira NLD; Guthrie KS; Motaghi M; Robinson GM; Shafaat O; Gong AJ; Weiss CR
    Am J Med Genet A; 2021 Jul; 185(7):1981-1990. PubMed ID: 33768677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ACVRL1 c.314-35A>G polymorphism is associated with organ vascular malformations in hereditary hemorrhagic telangiectasia patients with ENG mutations, but not in patients with ACVRL1 mutations.
    Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Young WL; Kim H; Faughnan ME;
    Am J Med Genet A; 2015 Jun; 167(6):1262-7. PubMed ID: 25847705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1.
    Snellings DA; Gallione CJ; Clark DS; Vozoris NT; Faughnan ME; Marchuk DA
    Am J Hum Genet; 2019 Nov; 105(5):894-906. PubMed ID: 31630786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational and clinical spectrum of Japanese patients with hereditary hemorrhagic telangiectasia.
    Kitayama K; Ishiguro T; Komiyama M; Morisaki T; Morisaki H; Minase G; Hamanaka K; Miyatake S; Matsumoto N; Kato M; Takahashi T; Yorifuji T
    BMC Med Genomics; 2021 Dec; 14(1):288. PubMed ID: 34872578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the ENG, ACVRL1, and SMAD4 genes and clinical manifestations of hereditary haemorrhagic telangiectasia: experience from the Center for Osler's Disease, Uppsala University Hospital.
    Karlsson T; Cherif H
    Ups J Med Sci; 2018 Sep; 123(3):153-157. PubMed ID: 30251589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and mutations in the ENG, ACVRL1, and SMAD4 genes in Korean patients with hereditary hemorrhagic telangiectasia.
    Lee ST; Kim JA; Jang SY; Kim DK; Do YS; Suh GY; Kim JW; Ki CS
    J Korean Med Sci; 2009 Feb; 24(1):69-76. PubMed ID: 19270816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations.
    Balachandar S; Graves TJ; Shimonty A; Kerr K; Kilner J; Xiao S; Slade R; Sroya M; Alikian M; Curetean E; Thomas E; McConnell VPM; McKee S; Boardman-Pretty F; Devereau A; Fowler TA; Caulfield MJ; Alton EW; Ferguson T; Redhead J; McKnight AJ; Thomas GA; ; Aldred MA; Shovlin CL
    Am J Med Genet A; 2022 Mar; 188(3):959-964. PubMed ID: 34904380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation affecting the proximal promoter of Endoglin as the origin of hereditary hemorrhagic telangiectasia type 1.
    Albiñana V; Zafra MP; Colau J; Zarrabeitia R; Recio-Poveda L; Olavarrieta L; Pérez-Pérez J; Botella LM
    BMC Med Genet; 2017 Feb; 18(1):20. PubMed ID: 28231770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant analysis in Chinese families with hereditary hemorrhagic telangiectasia.
    Zhao Y; Zhang Y; Wang X; Zhang L
    Mol Genet Genomic Med; 2019 Sep; 7(9):e893. PubMed ID: 31400083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ENG mutational mosaicism in a family with hereditary hemorrhagic telangiectasia.
    Tørring PM; Kjeldsen AD; Ousager LB; Brusgaard K
    Mol Genet Genomic Med; 2018 Jan; 6(1):121-125. PubMed ID: 29243366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New genetic drivers in hemorrhagic hereditary telangiectasia.
    Cerdà P; Castillo SD; Aguilera C; Iriarte A; Rocamora JL; Larrinaga AM; Viñals F; Graupera M; Riera-Mestre A
    Eur J Intern Med; 2024 Jan; 119():99-108. PubMed ID: 37689549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations.
    Nishida T; Faughnan ME; Krings T; Chakinala M; Gossage JR; Young WL; Kim H; Pourmohamad T; Henderson KJ; Schrum SD; James M; Quinnine N; Bharatha A; Terbrugge KG; White RI
    Am J Med Genet A; 2012 Nov; 158A(11):2829-34. PubMed ID: 22991266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational and phenotypic characterization of hereditary hemorrhagic telangiectasia.
    Shovlin CL; Simeoni I; Downes K; Frazer ZC; Megy K; Bernabeu-Herrero ME; Shurr A; Brimley J; Patel D; Kell L; Stephens J; Turbin IG; Aldred MA; Penkett CJ; Ouwehand WH; Jovine L; Turro E
    Blood; 2020 Oct; 136(17):1907-1918. PubMed ID: 32573726
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    El Hajjam M; Mekki A; Palmyre A; Eyries M; Soubrier F; Bourgault Villada I; Ozanne A; Carlier RY; Chinet T
    J Med Genet; 2021 Sep; 58(9):645-647. PubMed ID: 32900839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seven cases of hereditary haemorrhagic telangiectasia-like hepatic vascular abnormalities associated with
    Guilhem A; Dupuis-Girod S; Espitia O; Rivière S; Seguier J; Kerjouan M; Lavigne C; Maillard H; Magro P; Alric L; Lipsker D; Parrot A; Leguy V; Vanlemmens C; Guibaud L; Vikkula M; Eyries M; Valette PJ; Giraud S
    J Med Genet; 2023 Sep; 60(9):905-909. PubMed ID: 36813543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and genetic features of hereditary haemorrhagic telangiectasia (HHT) in central South Africa-three novel pathogenic variants.
    Mutize TT; Seedat RY; Ploos van Amstel JK; Mager JJ; Brown SC; Gebremariam F; Coetzee MJ
    Mol Biol Rep; 2020 Dec; 47(12):9967-9972. PubMed ID: 33201366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mutations in ENG and ACVRL1 identified in a series of 200 individuals undergoing clinical genetic testing for hereditary hemorrhagic telangiectasia (HHT): correlation of genotype with phenotype.
    Bossler AD; Richards J; George C; Godmilow L; Ganguly A
    Hum Mutat; 2006 Jul; 27(7):667-75. PubMed ID: 16752392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Executive summary of the 12th HHT international scientific conference.
    Andrejecsk JW; Hosman AE; Botella LM; Shovlin CL; Arthur HM; Dupuis-Girod S; Buscarini E; Hughes CCW; Lebrin F; Mummery CL; Post MC; Mager JJ
    Angiogenesis; 2018 Feb; 21(1):169-181. PubMed ID: 29147802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.